136 related articles for article (PubMed ID: 9195372)
61. Impact of intrinsic blood flow regulation in cirrhosis: maintenance of hepatic arterial buffer response.
Richter S; Mücke I; Menger MD; Vollmar B
Am J Physiol Gastrointest Liver Physiol; 2000 Aug; 279(2):G454-62. PubMed ID: 10915656
[TBL] [Abstract][Full Text] [Related]
62. Reduction of intrahepatic vascular space in the pathogenesis of portal hypertension. In vitro and in vivo studies in the rat.
Lee SS; Hadengue A; Girod C; Braillon A; Lebrec D
Gastroenterology; 1987 Jul; 93(1):157-61. PubMed ID: 3582902
[TBL] [Abstract][Full Text] [Related]
63. Beneficial hemodynamic effects of bosentan, a mixed ET(A) and ET(B) receptor antagonist, in portal hypertensive rats.
Sogni P; Moreau R; Gomola A; Gadano A; Cailmail S; Calmus Y; Clozel M; Lebrec D
Hepatology; 1998 Sep; 28(3):655-9. PubMed ID: 9731554
[TBL] [Abstract][Full Text] [Related]
64. Hepatic haemodynamic changes after portacaval anastomosis in normal, cirrhotic and chronic prehepatic portally hypertensive rats.
Romeo JM; Lopez-Farre A; Martin-Paredero V; Lopez-Novoa JM
Br J Surg; 1990 Mar; 77(3):335-8. PubMed ID: 2322805
[TBL] [Abstract][Full Text] [Related]
65. Thromboxane A2 from Kupffer cells contributes to the hyperresponsiveness of hepatic portal circulation to endothelin-1 in endotoxemic rats.
Xu H; Korneszczuk K; Karaa A; Lin T; Clemens MG; Zhang JX
Am J Physiol Gastrointest Liver Physiol; 2005 Feb; 288(2):G277-83. PubMed ID: 15647606
[TBL] [Abstract][Full Text] [Related]
66. The effect of mechanically enhancing portal venous inflow on hepatic oxygenation, microcirculation, and function in a rabbit model with extensive hepatic fibrosis.
Jiao LR; Seifalian AM; Habib N; Davidson BR
Hepatology; 1999 Jul; 30(1):46-52. PubMed ID: 10385637
[TBL] [Abstract][Full Text] [Related]
67. [Study on endothlin and its gene expression in splanchnic vessels in cirrhotic rats].
Yu J; Liang K; Tian D
Zhonghua Gan Zang Bing Za Zhi; 1999 Dec; 7(4):233-5. PubMed ID: 10715796
[TBL] [Abstract][Full Text] [Related]
68. Intrahepatic flow disturbance by clomipramine in the isolated perfused rat liver.
Masuda Y; Edo T; Suzuki S; Kawashima M; Sato M; Hirota A; Kimura A
Biochem Pharmacol; 2004 Dec; 68(11):2291-300. PubMed ID: 15498519
[TBL] [Abstract][Full Text] [Related]
69. Endogenous nitric oxide attenuates ethanol-induced perturbation of hepatic circulation in the isolated perfused rat liver.
Oshita M; Takei Y; Kawano S; Hijioka T; Masuda E; Goto M; Nishimura Y; Nagai H; Iio S; Tsuji S
Hepatology; 1994 Oct; 20(4 Pt 1):961-5. PubMed ID: 7927238
[TBL] [Abstract][Full Text] [Related]
70. Acute haemodynamic effects of losartan in anaesthetized cirrhotic rats.
Heller J; Shiozawa T; Trebicka J; Hennenberg M; Schepke M; Neef M; Sauerbruch T
Eur J Clin Invest; 2003 Nov; 33(11):1006-12. PubMed ID: 14636305
[TBL] [Abstract][Full Text] [Related]
71. Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats.
Gupta TK; Toruner M; Chung MK; Groszmann RJ
Hepatology; 1998 Oct; 28(4):926-31. PubMed ID: 9755227
[TBL] [Abstract][Full Text] [Related]
72. Reduced splanchnic vasoconstriction to angiotensin II in conscious rats with biliary cirrhosis.
Braillon A; Cailmail S; Gaudin C; Lebrec D
J Hepatol; 1993 Jan; 17(1):86-90. PubMed ID: 8445224
[TBL] [Abstract][Full Text] [Related]
73. Localization of increased hepatic vascular resistance in liver cirrhosis.
Shibayama Y; Nakata K
Hepatology; 1985; 5(4):643-8. PubMed ID: 4018737
[TBL] [Abstract][Full Text] [Related]
74. Effect of the ligation of hepatic artery on the microcirculation in the cirrhotic liver in the rat.
Koo A; Liang IY; Cheng KK
Aust J Exp Biol Med Sci; 1976 Jun; 54(3):287-95. PubMed ID: 1016126
[TBL] [Abstract][Full Text] [Related]
75. Enoxaparin does not ameliorate liver fibrosis or portal hypertension in rats with advanced cirrhosis.
Fortea JI; Zipprich A; Fernandez-Mena C; Puerto M; Bosoi CR; Almagro J; Hollenbach M; Bañares J; Rodríguez-Sánchez B; Cercenado E; Clément MA; Rose CF; Bañares R; Vaquero J; Ripoll C
Liver Int; 2018 Jan; 38(1):102-112. PubMed ID: 28665498
[TBL] [Abstract][Full Text] [Related]
76. Mechanisms of a clonidine-induced decrease in portal pressure in normal and cirrhotic conscious rats.
Roulot D; Braillon A; Gaudin C; Ozier Y; Girod C; Lebrec D
Hepatology; 1989 Oct; 10(4):477-81. PubMed ID: 2777209
[TBL] [Abstract][Full Text] [Related]
77. Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilators.
Bhathal PS; Grossman HJ
J Hepatol; 1985; 1(4):325-37. PubMed ID: 4056346
[TBL] [Abstract][Full Text] [Related]
78. [An experimental study of regional spontaneous portasystemic shunt in cirrhotic rats].
Huang Y; Fan L
Zhonghua Wai Ke Za Zhi; 1996 Mar; 34(3):133-7. PubMed ID: 9387663
[TBL] [Abstract][Full Text] [Related]
79. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats.
Niederberger M; Ginés P; Martin PY; Tsai P; Morris K; McMurtry I; Schrier RW
Hepatology; 1996 Oct; 24(4):947-51. PubMed ID: 8855203
[TBL] [Abstract][Full Text] [Related]
80. Increased myoendothelial gap junctions mediate the enhanced response to epoxyeicosatrienoic acid and acetylcholine in mesenteric arterial vessels of cirrhotic rats.
Bolognesi M; Zampieri F; Di Pascoli M; Verardo A; Turato C; Calabrese F; Lunardi F; Pontisso P; Angeli P; Merkel C; Gatta A; Sacerdoti D
Liver Int; 2011 Jul; 31(6):881-90. PubMed ID: 21645220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]